United Therapeutics announces settlement of patent litigation with Actavis Laboratories
United Therapeutics announced a Settlement Agreement with Actavis resolving ongoing litigation concerning certain patents relating to United Therapeutics' product, Orenitram® (treprostinil) ER Tablets, and Actavis' NDA seeking approval by the FDA to market a generic version of Orenitram. February 16, 2018